PureIMS formerly PIMS-E (a University of Groningen Spin-off) is developing an alternative for the Epipen™ via inhalation of Epinephrine by persons in a life-threatening reaction after exposure to an allergen that is dangerous to them. The advantages is the very short exposure time of dry-powder inhalation, one no longer has to give oneself an injection and the medicine has a long shelf life (and does not have to be kept in the refrigerator either).

Website: https://pureims.com/